Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., 1120 Veterans Blvd., South San Francisco, CA 94080, USA.
Drug Metab Dispos. 2011 Dec;39(12):2387-94. doi: 10.1124/dmd.111.039545. Epub 2011 Aug 24.
Sandwich-cultured rat hepatocytes are used in drug discovery for pharmacological and toxicological assessment of drug candidates, yet their utility as a functional model for drug transporters has not been fully characterized. To evaluate the system as an in vitro model for drug transport, expression changes of hepatic transporters relative to whole liver and freshly isolated hepatocytes (day 0) were examined by real-time quantitative reverse transcription-polymerase chain reaction for 4 consecutive days of culture. No significant differences in transporter expression levels were observed between freshly isolated hepatocytes and whole liver. Two distinct mRNA profiles were detected over time showing 1) a more than 5-fold decline in levels of uptake transporters such as Na(+)-taurocholate cotransporting polypeptide (Ntcp), organic anion transporter (Oat) 2, organic anion-transporting polypeptide (Oatp) 1a1, Oatp1a4, and Oatp1b2 and 2) a greater than 5-fold increase of efflux transporters P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and multidrug resistance-related proteins (Mrp) 1, 2, 3, and 4. In addition, protein levels and functional activities for selected transporters were also determined. Protein levels for Mrp2, Bcrp, P-gp, Ntcp, and Oatp1a4 corresponded to changes in mRNA. Functional activities of Oatps and Oct1 exhibited a 3- and 4-fold decrease on day 2 and day 4, respectively, relative to that on day 0, whereas a more than 10-fold reduction in Oat2 activity was observed. These results indicate that the cell culture conditions used herein did not provide an optimal environment for expression of all hepatic transporters. Significant time-dependent alterations in basal gene expression patterns of transporters were detected compared with those in liver or freshly isolated hepatocytes. Further work and new strategies are required to improve the validity of this model as an in vitro tool for in vivo drug transport or biliary clearance prediction.
夹层培养的大鼠肝细胞被用于药物发现,以评估候选药物的药理学和毒理学,但其作为药物转运体的功能模型的实用性尚未得到充分描述。为了评估该系统作为药物转运的体外模型,通过实时定量逆转录聚合酶链反应(qRT-PCR)在连续 4 天的培养过程中,检测相对于整个肝脏和新鲜分离的肝细胞(第 0 天)的肝细胞转运体的表达变化。在新鲜分离的肝细胞和整个肝脏之间,未观察到转运体表达水平的显著差异。随着时间的推移,检测到两种不同的 mRNA 谱,分别为 1)摄取转运体(如 Na(+)-牛磺胆酸钠共转运多肽(Ntcp)、有机阴离子转运体(Oat)2、有机阴离子转运多肽(Oatp)1a1、Oatp1a4 和 Oatp1b2)的水平下降超过 5 倍,以及 2)外排转运体 P-糖蛋白(P-gp)、乳腺癌耐药蛋白(Bcrp)和多药耐药相关蛋白(Mrp)1、2、3 和 4 的水平增加超过 5 倍。此外,还确定了选定转运体的蛋白水平和功能活性。Mrp2、Bcrp、P-gp、Ntcp 和 Oatp1a4 的蛋白水平与 mRNA 的变化相对应。Oatps 和 Oct1 的功能活性分别在第 2 天和第 4 天相对于第 0 天下降了 3 倍和 4 倍,而 Oat2 的活性下降了 10 多倍。这些结果表明,本文中使用的细胞培养条件未能为所有肝转运体的表达提供最佳环境。与肝脏或新鲜分离的肝细胞相比,检测到转运体的基础基因表达模式随时间发生显著变化。需要进一步的工作和新策略来提高该模型作为体内药物转运或胆汁清除预测的体外工具的有效性。